The United States of America, as represented by The Secretary, Department of Health and Human Services;Kite Pharma, Inc.
发明人:
申请号：
EP16800846.4
公开号：
EP3302507A4
申请日:
2016.05.27
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes methods of identifying a patient who would respond well to a T cell therapy or conditioning a patient prior to a T cell therapy so that the patient responds well to a T cell therapy. The conditioning involves administering one or more preconditioning agents prior to a T cell therapy and identifying biomarker cytokines prior to administering a T cell therapy.
